Bo Ren

This inventor holds 13 USPTO granted patents and 3 published patent applications and 7 EPO patents. Top assignees: Beigene, Ltd., Purdue Research Foundation. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bo Ren. Retrieved from https://idiyas.com/inventor/bo-ren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 92.3

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 151(Granted Patents)

Company Filing History:

Purdue Research Foundation

patents

Years Active: 2016-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404517 - Rhizobial tRNA-derived small RNAs and uses thereof for regulating plant nodulation (2025-09-02),

2. 11202782 - Treatment cancers using a combination comprising PARP inhibitors (2021-12-21),

3. 10882856 - 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases (2021-01-05),

4. 10647714 - 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases (2020-05-12),

5. 10501467 - Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors (2019-12-10),

6. 10457680 - Process for preparing a PARP inhibitor, crystalline forms, and uses thereof (2019-10-29),

7. 10280163 - 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases (2019-05-07),

8. 10112952 - Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors (2018-10-30),

9. 9827226 - Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones (2017-11-28),

10. 9617273 - Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors (2017-04-11),

11. 9393232 - Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones (2016-07-19),

12. 9328111 - Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors (2016-05-03),

13. 9260440 - Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors (2016-02-16),

Title: The Innovative Journey of Bo Ren

Introduction: Bo Ren is a visionary inventor based in Beijing, China, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Bo Ren's latest patents focus on artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we approach transportation and safety on the roads.

Career Highlights: With a career spanning over two decades, Bo Ren has been at the forefront of innovation, leading research teams in developing cutting-edge solutions for various industries. His work has significantly impacted the fields of robotics, renewable energy, and healthcare.

Collaborations: Bo Ren has collaborated with top research institutions and multinational companies to bring his ideas to life. His partnerships have led to the successful implementation of novel technologies in real-world applications.

Conclusion: Bo Ren's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the world of inventions. His work continues to inspire and shape the landscape of modern innovation.

Profile summary based on public USPTO records.